MDRX.OTC.PinkVeradigm INC

SCHEDULE: Two Seas Capital Discloses 8.2% Stake in Veradigm Inc.

Sentiment:

Schedule 13G Amendment


Two Seas Capital LP has filed an amended Schedule 13G reporting an 8.2% beneficial ownership stake in Veradigm Inc.

Summary

  • Two Seas Capital LP, Two Seas Capital GP LLC, and Sina Toussi collectively report beneficial ownership of 8,943,265 shares of Veradigm Inc. common stock.
  • This holding represents 8.2% of the company's outstanding common stock.
  • The shares are held by the Two Seas Global (Master) Fund LP, for which Two Seas Capital LP serves as the investment manager.
  • The reporting persons maintain sole voting and dispositive power over the entire 8,943,265 share position.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral regulatory disclosure confirming institutional interest without indicating any immediate change in corporate strategy or control.

Positives

  • Institutional investor maintains a significant 8.2% stake, signaling long-term interest in the issuer.
  • The filing confirms the shares were acquired in the ordinary course of business without intent to change or influence control.

Negatives

  • None identified in this regulatory disclosure.

Risks

  • Market volatility affecting the value of the 8.2% equity position.
  • Reliance on the accuracy of the issuer's reported outstanding share count (108,800,000) for percentage calculations.

Future Outlook

The reporting persons certify that the securities were not acquired for the purpose of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that this filing represents a standard institutional disclosure of a significant minority position, which is common in the healthcare technology sector as investment firms build stakes in companies undergoing strategic transitions.

Comparison to Industry Standards

  • The filing follows standard SEC Schedule 13G requirements for passive institutional investors.
  • The 8.2% stake is consistent with typical 'active-passive' investment strategies seen in mid-cap healthcare technology firms.

Stakeholder Impact

  • Shareholders may view the continued 8.2% stake as a sign of institutional confidence in the company's long-term prospects.

Next Steps

  • Continued monitoring of future 13G/13D filings for changes in position size or intent.

Key Dates

DateDescription
2025-12-31Date used for total shares outstanding calculation.
2026-02-17Date of Issuer's Form 8-K disclosing outstanding shares.
2026-03-31Date of event requiring the filing of this statement.
2026-05-15Date of signature and filing of the Schedule 13G.

Keywords

Veradigm, Two Seas Capital, Schedule 13G, Institutional Ownership, Equity Stake, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.